Carl Zeiss Meditec AG
Global website (English)
back
Carl Zeiss Meditec AG
recommended searches
popular searches

Financial Publications

New products are the key to our company's success. This innovative strength is the driving force of our growth. In this section we present facts and figures on the company's financial position.

The Management Board

  • Third-party Content Blocked

    The video player is blocked due to your tracking preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

Downloads

Key Financial Figures

2022/232
2021/222
2020/212

€m

%

€m

%

€m

%

Revenue

2,089.3

100

1,902.8

100  

1,646.8

100

Research and development expenses

349.3

16.7

291.4

15.3 

232.1

14.1

EBIT

348.1
 

16.7

363.9 

20.9

373.6

22.7

Consolidated profit3

292.0
 

14.0

295.9 

15.6

237.5

14.4

Earnings per share4
(in €)

3.25

3.29

2.64

Dividend per share
(in €)

1.105

1.105

0.905

Cash flows from operating activities
  

250.9

188.2

362.7

Cash flows from investing activities
  

-111.0

-148.9

-71.2

Cash flows from financing activities
-135.1

-38.2

-289.9

Total assets
  

3,032.9 

100

2,822.8

100  

2,396.0

 

100

Property, plant and equipment

315.8 
 

10.4

236.4

8.4 

199.6

8.3

Equity

2,172.9 

71.6 

2,030.1

71.9 

1,677.4

70.0

Net cash6

863.9
 

28.5

885.6

30.3

939.9

39.2

Employees at end of reporting period (30 September)

4,823

4,224

3,531
  • 1

    Ending 30 September
  • 2

    Consolidated figures according to IFRS
  • 3

    Before non-controlling interests
  • 4

    Earnings/(loss) per share attributable to the shareholders of the parent company in the fiscal year
  • 5

    Amount by the Supervisory Board and the Management Board of Carl Zeiss Meditec AG
  • 6

    Cash and cash equivalents plus treasury receivables from/payables to the treasury of Carl Zeiss AG